Dr Arnab Basu is the founding CEO of Kromek Group plc, a supplier of patented radiation detection technologies to the Medical Imaging, Nuclear Detection and Security Screening markets globally with operations in Durham and Huddersfield in the UK, and Pennsylvania and California in the USA.
Dr Basu successfully led Kromek through five rounds of private equity financing of over $40 million, including its first institutional Venture Capital funding in 2005. More recently, he led the successful acquisition and integration of California based NOVA R&D Inc., in 2010; eV Products Inc., in Pennsylvania, US, in 2013 and a successful listing on AIM, at the London Stock Exchange, in October 2013, raising over $65m in the market. Arnab has extensive experience in international business in USA, Europe, Middle East and Asia and has led M&A’s, formed strategic partnerships and raised equity. Arnab has also been part of many trade missions including a Prime Minister led mission to India in November 2016 and has led UK trade missions to Asia.
A prominent figure within the business community, Dr Basu is currently chair of the Academic Health Science Network for the North East and North Cumbria (AHSN) and council member of Innovate UK
He previously served as a Board member of the North East LEP (leading Inward Investment), the Go-Global Partnership (trade contract delivery for UKTI), the North-East Innovation Strategy Board, Business Durham, a member of the International Advisory Board of Newcastle University Business School, chair for the steering group of Health Quest (Grand Challenge) for the North East LEP (Local Enterprise Partnership) and is a founding member of Northern Futures UTC (University Training College in partnership with Sunderland University), in Newcastle.